Are Hong Kong IVF Success Rate Data Real? Data Verification & Statistical Caliber Analysis

AI Summary

Patient Misconceptions

"Is the success rate of IVF in Hong Kong as high as 60% or even 70%?" In the clinic, we encounter patients asking this question almost every week, holding screenshots on their phones. The screenshots often show numbers from a hospital's official website or an intermediary platform: "Clinical pregnancy rate 68%" "Live birth rate under 35 years old 55%". But do these numbers really represent your situation? More importantly — can these numbers themselves withstand scrutiny?

As a practitioner with ten years of experience in the field of assisted reproduction, I need to honestly tell you: Hong Kong IVF success rate data is not necessarily "false," but it can easily be "misinterpreted." The problem lies in statistical caliber, patient selection, and disclosure methods. Below, we break down the logic behind the data from a knowledge base perspective, and how you can judge for yourself whether these numbers are trustworthy.

A Direct Answer to the Question

Are Hong Kong IVF Success Rate Data Real? A Direct Answer

Partially real, but easily overestimated. The Hong Kong Council on Human Reproductive Technology (HTA) requires all licensed centers to report treatment data and publishes an annual report. However, the "success rate" in the report is usually presented as the "clinical pregnancy rate" (ultrasound confirmation of a gestational sac) rather than the "live birth rate," and stratification by age, embryo grade, or transfer cycle type (fresh/frozen) is not mandatory. Private hospital websites or promotional materials often use statistical calibers favorable to themselves, for example, only calculating data for "under 35 years old," "single transfer," or "PGT-normal embryos," leading to inflated numbers.

The core method to judge whether data is credible is: Ask the other party to provide the live birth rate stratified by age, and clarify whether the denominator is "transfer cycles" or "egg retrieval cycles."

B Why Does This Problem Arise

Why Do Differences Exist in Hong Kong IVF Success Rate Data?

Differences mainly arise from three levels:

• Inconsistent statistical calibers: "Clinical pregnancy rate," "ongoing pregnancy rate," and "live birth rate" are three completely different indicators. The clinical pregnancy rate is usually 10-15 percentage points higher than the live birth rate. Some institutions only publish the clinical pregnancy rate, giving patients the illusion of "successfully having a baby."
• Patient selection bias: Some centers primarily treat patients with "good ovarian reserve and young age," so their success rates are naturally higher than centers that accept older patients or those with poor ovarian response. Without age stratification, overall data is meaningless for comparison.
• Impact of transfer strategy: A center that only performs "single blastocyst transfers" may have a higher single-transfer success rate than a center that performs "double embryo transfers," but its cumulative live birth rate may be lower. Patients need the cumulative live birth rate, not just the single-transfer success rate.

G The Most Easily Overlooked Detail

The Most Easily Overlooked Detail: Data Denominator and Audit Method

When looking at any success rate data, first ask three questions:

• What is the denominator? — Is it "egg retrieval cycles," "transfer cycles," or "number of patients"? Data using "transfer cycles" as the denominator is usually higher than data using "egg retrieval cycles" because not all egg retrieval cycles lead to a transfer.
• Does it include frozen embryo transfers? — Fresh embryo transfer success rates are usually lower than frozen embryo transfers (due to endometrial stimulation and hormonal effects). If data only counts frozen embryo transfers, it will appear higher.
• Is there a third-party audit? — Data in the Hong Kong HTA report is officially verified, but self-reported data from private hospitals may not be audited. You can ask to see the center's data in the HTA annual report.

H The Most Common Pitfalls

The Most Common Pitfalls: Being Misled by "Packaged Data"

Here are several common ways data is packaged, requiring special attention:

• Mentioning only the "clinical pregnancy rate" without the "live birth rate": Miscarriage can occur after clinical pregnancy, especially in older age groups where the miscarriage rate can exceed 30%. The live birth rate is the ultimate goal.
• "Live birth rate 55% for under 35" seems real, but the sample size is not stated: If patients under 35 make up only 10% of the center's cases, the sample size is very small, and this percentage fluctuates greatly, lacking statistical stability.
• "Success rate of 70% for PGT-normal embryo transfer": The chromosome normality rate of embryos after PGT screening improves, but PGT itself results in the loss of some embryos (about 20-30% cannot be biopsied or have abnormal results), and miscarriage rates still exist after PGT. This "70%" does not apply to those who have not undergone PGT.
• Simple comparison with mainland data: The age distribution of patients, causes of infertility, and medical systems differ between Hong Kong and the mainland, making direct comparison meaningless. The average age of patients in Hong Kong is higher than in the mainland; without age adjustment, data comparability is extremely low.

D Differences Across Age Groups

Success Rate Differences Across Age Groups: Data Stratification is Key

Age is the most critical factor affecting IVF success rates, bar none. Below are typical ranges based on Hong Kong HTA annual reports and public data from multiple centers (live birth rate per transfer cycle, including fresh and frozen embryos):

If a hospital publishes an "overall live birth rate" exceeding 50%, and it also accepts a large number of patients over 38, this data needs to be questioned. Under a normal distribution, the overall live birth rate is approximately 30-40% (calculated per transfer cycle). A rate higher than this range usually implies strict patient selection.

M Case Scenario Analysis

Case Scenario Analysis: Why Do Different People Interpret the Same Data Completely Differently?

Scenario 1: A 37-year-old woman, AMH 1.2 ng/mL, low ovarian reserve

A center tells her, "Our live birth rate for ages 35-37 is 42%." But this 42% is calculated based on cycles where "at least one blastocyst is available for transfer." After her egg retrieval, she may have no embryos for transfer, or may only be able to transfer a day-3 cleavage-stage embryo. Her personal success rate could be much lower than 42%. Key point: Is the data denominator "transfer cycles" or "egg retrieval cycles"? If it's "transfer cycles," it has limited reference value for someone with low ovarian reserve, as she may not reach the transfer stage.

Scenario 2: A 41-year-old woman, no PGT, wants to know the real live birth rate

A center's website shows "Clinical pregnancy rate for ages 41-42: 22%," but does not mention the live birth rate. The actual live birth rate for this age group is about 10-15%, because the miscarriage rate is over 40%. If she only looks at the clinical pregnancy rate, she might mistakenly believe she has a 22% chance of taking a baby home, but the real chance is at least halved. Key point: Ask for the "live birth rate" rather than the "clinical pregnancy rate."

Q Frequently Asked Questions

Frequently Asked Questions: 4 Most Common Data-Related Questions from Patients

• Q: Is it true that Hong Kong IVF data is higher than mainland data?
  A: Not necessarily. Patients in Hong Kong tend to be older, but laboratory standards and embryo culture techniques are generally higher. Direct comparison of overall data is meaningless; age-stratified data needs to be compared. Data for young patients from some top mainland centers is not lower than that in Hong Kong.
• Q: How do I read the Hong Kong Council on Human Reproductive Technology report?
  A: The HTA publishes the "Annual Report on Assisted Reproductive Services in Hong Kong," which includes the number of egg retrieval cycles, transfer cycles, clinical pregnancies, multiple pregnancy rates, etc., for each center. However, the report does not disclose the live birth rate stratified by age for each center; you need to request this from the center directly.
• Q: A hospital claims a 60% success rate. Is it a lie?
  A: Not necessarily. 60% could be the "clinical pregnancy rate for a single transfer of a PGT-normal blastocyst in women under 35." But whether it applies to you depends on your age and embryo situation. Ask them to provide live birth rate data matching your age.
• Q: Why do different doctors at the same hospital give different success rates?
  A: Doctors may give a personalized estimate based on your specific situation, while the promotional data is an "average." Personalized estimates tend to be more conservative. Rely on the doctor's individualized assessment, not the numbers on the brochure.

R Practitioner Observations

Practitioner Observations: What Should Patients Focus on Behind the Data?

Over the past ten years, I have handled thousands of families. Regarding success rate data, here are some real observations I want to share:

• Truly reliable data comes from the "cumulative live birth rate" — the probability of eventually taking a baby home from one egg retrieval cycle (including all subsequent frozen embryo transfers). This data reflects a center's true level more accurately than the single-transfer success rate, but few hospitals proactively disclose it.
• The "gold standard" for data verification is a third-party audit. The Hong Kong HTA report is audited, but hospital self-reported data may not be. If a hospital is willing to let you see the raw data for that center in the HTA report, credibility is much higher.
• Beware of the "data selection" trap. Some centers only publish data for "PGT cycles" or "frozen embryo transfer cycles" because these numbers look better. Always ask clearly which cycles the data comes from.
• Don't just compare data; compare the "patient population." If a center accepts many patients with premature ovarian failure, advanced age, or repeated failure, its overall data may be lower than a center that "only accepts standard patients," but its true capability may be stronger. Data must be viewed in the context of the patient population.

Ending: Risk Reminder